ASPIRA WOMEN-S HEALTH INC.
Profile
Company Names
ASPIRA WOMEN-S HEALTH INC.
VERMILLION, INC.
Addresses
12117 BEE CAVES ROAD, BUILDING III, SUITE 100, AUSTIN, TX 78738
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738
12117 BEE CAVES ROAD, BUILDING THREE, SUITE 100, AUSTIN, TX 78738
47350 FREMONT BLVD., FREMONT, CA 94538
Phone Numbers
(512) 519-0400
512-519-0400
510-226-2800
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER HEALTH CARE
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$79,610,588.00
Number of Funding Rounds:
7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2026-06-05
$1,485,000.00
$1,485,000.00
$0.00
Equity
6
2025-09-16
$2,950,000.00
$2,950,000.00
$0.00
Equity
5
2025-03-05
$1,370,000.00
$1,370,000.00
$0.00
Equity, Debt
4
2024-01-26
$6,488,230.00
$6,488,230.00
$0.00
3
2020-07-01
$11,025,000.00
$11,025,000.00
$0.00
Equity
2
2013-05-13
$13,242,500.00
$13,242,500.00
$0.00
Equity
1
2010-01-07
$43,049,858.00
$43,049,858.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES
S.
BURNS
DIRECTOR
STEFANIE
CAVANAUGH
DIRECTOR
JEFFREY
COHEN
DIRECTOR
HALT MEDICAL INC
| G-SNAP!, INC.
| SCHOOL OF ROCK, LLC
| PHOTO DIAGNOSTIC SYSTEMS, INC.
| WELLTOK, INC.
| STONEWEDGE CORP
| HALT MEDICAL, INC
| NEUROLOGICA CORP
| AMERICAN BANK HOLDINGS INC
| K-PAX PHARMACEUTICALS, INC.
| DISTRESSED OPPORTUNITIES FUND II LLC
| ZAPGO LTD.
| INTERNATIONAL VALUE INVESTMENTS LLC
| INTERNATIONAL SELECT INVESTMENTS, LLC
| THRIVE SOFTWARE, INC.
| LEADOFF.AI, INC.
| ASPIRA WOMEN-S HEALTH INC.
JAMES
CRAWFORD
EXECUTIVE OFFICER
JOHN
FRASER
EXECUTIVE OFFICER, DIRECTOR
TNR GOLD CORP
| MEDNETWORLD.COM, INC.
| MEDNETWORLD.COM, INC.
| APENIMED, INC.
| JUNIUS SALAMANDER CAYMAN 4 LP
| JUNIUS SALAMANDER CAYMAN 3 LP
| JUNIUS SALAMANDER CAYMAN 2 LP
| JUNIUS SALAMANDER CAYMAN 1 LP
| JUNIUS SALAMANDER TE LP
| JUNIUS SALAMANDER LP
| JUNIUS SALAMANDER US LP
| 3I US SENIOR LOAN FUND, L.P.
| 3I US SENIOR LOAN FUND INTERNATIONAL, L.P.
| JUNIUS CAA LP
| JUNIUS CAA US LP
| JUNIUS CAA CAYMAN LP
| JPP US LP
| JPP MASTER LP
| JPP CAYMAN 3 LP
| BRYANT STREET CIV LP
| BRYANT STREET CIV US LP
| OCS US LP
| OCS MASTER LP
| BEL AIR CIV US LP
| BEL AIR CIV LP
| LVH CIV LP
| LVH CIV US LP
| JHP MASTER LP
| JHP US LP
| PROGRAM II US LP
| PROGRAM II MASTER LP
| PROGRAM II CAYMAN 2 LP
| CHICAGO 21 US LP
| CHICAGO 21 MASTER LP
| 14TH STREET CIV US LP
| 14TH STREET CIV LP
| PATTERSON STREET CIV US LP
| PATTERSON STREET CIV LP
| CS PE US LP
| CS PE MASTER LP
| CROSS RIVER VENTURES CORP.
| TREATMENT.COM INTERNATIONAL INC.
| ASPIRA WOMEN-S HEALTH INC.
THOMAS
MCLAIN
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2026-06-05
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2025-09-16
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity, Debt
2025-03-05
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
2024-01-26
D
OTHER HEALTH CARE
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2020-07-01
D
OTHER HEALTH CARE
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
$1,000,001 - $5,000,000
Equity
2013-05-13
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2010-01-07
